Source: Annual Congress 2009 - Biomarkers and biology in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kochetkova, Y. Maistrovskay, V. Nevzorova, R. Kessler, G. Massard (Strasbourg, France; Vladivostok, Russian Federation). The effects of serum leptin on bone metabolism in chronic obstructive pulmonary disease. Eur Respir J 2009; 34: Suppl. 53, 430

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin level may be a predictor of bone mineral loss in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 688s Year: 2007 Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 Plasma inflammatory markers associated with bone resorption in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008 Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Plasma orexin-A level and body composition in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 485s Year: 2001 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Role of oxidative-antioxidative imbalance and thyroid hormones in stable chronic obstructive pulmonary disease Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Serum magnesium levels of patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Low testosterone in chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The effect of inferon on oxygen-dependent metabolism of blood cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015